In the Field - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Field

Pharmaceutical Technology


INTERACT in FEBRUARY...

"Worth reading

Protein Formulation and Delivery, Second Edition (Informa Healthcare, 2007)

Eds. Eugene J. McNally and Jayne E. Hastedt




The book summarizes recent research for formulators and drug-delivery specialists. Reviewed on http://pharmtech.com/.

"Worth attending

Interphex Puerto Rico

Venue: Feb. 14–Feb. 15, San Juan, PR

More Info: http://www.interphexpuertorico.com/

Biogenerics 2008: An Open Forum on Scientific and Regulatory Issues

Venue: Mar. 2–Mar. 4, Boston, MA

More Info: http://www.barnett.neu.edu/biogenerics/

WBF 2008 North American Conference: Shaping the Future of Manufacturing

Venue: Mar.24-Mar. 27, Philadelphia, PA

More Info: http://www.wbf.org/

Interphex 2008

Venue: Mar. 26-28, Philadelphia, PA

More Info: http://www.interphex.com/




See special pullout in this issue.

To recommend books, events, or websites, email


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Pharmaceutical Technology,
Click here